Introduction:

At the beginning of the 21st century, the blood deficit and transfusion risks determined the adoption of a restrictive transfusion policy, with hemoglobin levels between 70 and 100 g/L for cardiovascular patients in the world. In the Institute of Cardiology and Cardiovascular Surgery, this policy was adopted for which it is necessary to control compliance, to make a rational and safe use of this resource.

Objective:

Evaluate compliance with the restrictive transfusion policy of the Institute of Cardiology and Cardiovascular Surgery between 2019 and 2021.

Method:

An observational descriptive cross-sectional study was carried out by reviewing the records of transfused patients and transfusion orders, which allowed reaching results.

Results:

5 408 hem components were transfused, 64,1 % were packed erythrocytes. The services with the highest consumption were the post-surgical intensive care unit 53,2 %, the operating room 22,8 % and the emergency intensive care unit 10,8 %. The mean of the hematocrit/hemoglobin values of the transfused patients was 0,24/79,2 g/L, lower 0,22/72,6 g/L for those operated on for severe heart valve disease. 95,9% of the transfusion orders met the regulatory requirements. The main problem was the omission of transfusion history.

Conclusion:

The restrictive transfusion policy was complied with. The mean hematocrit/hemoglobin values were lower than those recommended for cardiovascular patients in The Cuban guidelines. The quality of the transfusion orders was adequate.

        · resumen en Español     · texto en Español     · Español ( pdf )